beta-lapachone has been researched along with Gram-Positive Bacterial Infections in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
Gram-Positive Bacterial Infections: Infections caused by bacteria that retain the crystal violet stain (positive) when treated by the gram-staining method.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lourenço, AL | 1 |
| Abreu, PA | 1 |
| Leal, B | 1 |
| da Silva Júnior, EN | 1 |
| Pinto, AV | 1 |
| Pinto, Mdo C | 1 |
| Souza, AM | 1 |
| Novais, JS | 1 |
| Paiva, MB | 1 |
| Cabral, LM | 1 |
| Rodrigues, CR | 1 |
| Ferreira, VF | 1 |
| Castro, HC | 1 |
1 other study available for beta-lapachone and Gram-Positive Bacterial Infections
| Article | Year |
|---|---|
Identification of nor-β-lapachone derivatives as potential antibacterial compounds against Enterococcus faecalis clinical strain.
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Microbial | 2011 |